Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials
Maarten W. Taal, Nicholas M. Selby
Topics & Concepts
MedicineGlucagon-like peptide-1KidneyGlucagon-like peptide 1 receptorReceptorInternal medicinePharmacologyEndocrinologyDiabetes mellitusAgonistType 2 diabetesDiabetes Treatment and ManagementDiabetes Management and ResearchGastroesophageal reflux and treatments